In this paper we report the results of a study aimed at translating and culturally validating the quality of life instrument QLQ-C30 initially developed by the European Organization for Research and Treatment of Cancer (EORTC). We begin by mentioning the forward-backward translations process used to construct a Portuguese version semantically equivalent to the original version. After minor revisions, the instrument was pilot tested in fifteen patients with breast cancer. A brief description of the results of the pilot test with women with breast cancer and with other two studies (mastectomized women and women with lymphomas) is presented in this paper as well as the results of the comparison with the other generic and specific outcome instr...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...
Introduction: Health-related quality of life assessment is increasingly important as it can help bot...
The aim of the present study was to verify the measurement properties of the generic Quality of Life...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Background: The European Organisation for Research and Treatment of Cancer quality of life (EORTC QL...
The purpose of this study was to validate the core EORTC quality of life questionnaire, the QLQ-C30 ...
Health-related quality of life is often an endpoint in oncology clinical trials. The European Organi...
Objective: To validate and assess reliability and understanding of the EORTC–C30 quality of life que...
Title: Translation, cultural adaptation and validation of the European Organisation of Research and ...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one ...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one ...
Abstract Objective: to describe the process of semantic equivalence, the first stage in the validat...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...
Introduction: Health-related quality of life assessment is increasingly important as it can help bot...
The aim of the present study was to verify the measurement properties of the generic Quality of Life...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Background: The European Organisation for Research and Treatment of Cancer quality of life (EORTC QL...
The purpose of this study was to validate the core EORTC quality of life questionnaire, the QLQ-C30 ...
Health-related quality of life is often an endpoint in oncology clinical trials. The European Organi...
Objective: To validate and assess reliability and understanding of the EORTC–C30 quality of life que...
Title: Translation, cultural adaptation and validation of the European Organisation of Research and ...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one ...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one ...
Abstract Objective: to describe the process of semantic equivalence, the first stage in the validat...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 was one...